Determination of P450 concentration.
Concentration of P450/P411 enzymes was accomplished by quantifying the amount of free hemin present in purified protein using the pyridine/hemochrome assay.
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Protein expression and purification. Enzymes used in purified protein experiments were expressed in BL21(DE3) E. coli cultures transformed with plasmid encoding P450 or P411
variants. Expression and purification was performed as described elsewhere, 3 except that the shake rate was lowered to 130 RPM during expression. Following expression, cells were pelleted and frozen at -20 °C. For purification, frozen cells were resuspended in buffer A (20 mM tris, 20 mM imidazole, 100 mM NaCl, pH 7.5, 4 mL/g of cell wet weight) and disrupted by sonication (2 x 1 min, output control 5, 50% duty cycle; Sonicator 3000, Misonix, Inc.). To pellet insoluble material, lysates were centrifuged at 24,000 x g for 0.5 h at 4 °C. Proteins were expressed in a construct containing a 6x-His tag and were consequently purified using a nickel NTA column (5 mL HisTrap HP, GE Healthcare, Piscataway, NJ) using an AKTAxpress purifier FPLC system (GE healthcare). P450 or P411 enzymes were then eluted on a linear gradient from 100% buffer A 0% buffer B (20 mM tris, 300 mM imidazole, 100 mM NaCl, pH 7.5) to 100 % buffer B over 10 column volumes (P450/P411 enzymes elute at around 80 mM imidazole). Fractions containing P450 or P411 enzymes were pooled, concentrated, and subjected to three exchanges of phosphate buffer (0.1 M KPi pH 8.0) to remove excess salt and imidazole. Concentrated proteins were aliquoted, flash-frozen on powdered dry ice, and stored at -20 °C until later use.
Typical procedure for small-scale sulfimidation bioconversions under anaerobic conditions using purified enzymes. Small-scale reactions (400 µL) were conducted anaerobically in 2 mL crimp vials as described previously. 3 A solution of aryl sulfide in DMSO or methanol (100 mM, 10 µL) was added to the reaction vial via syringe, followed by arylsulfonyl azide (100 mM, 10 µL, DMSO). Final concentrations of the reagents were typically: 2.5 mM aryl sulfide, 2.5 mM arylsulfonyl azide, 10 mM NADPH, 25 mM glucose, 5-20 µM P450. To the vials were then added acetonitrile (460 µL) and internal standard (1, 3, 5 trimethoxybenzene, 10 mM in 10% DMSO/90% acetonitrile, 1 mM final concentration). This mixture was then transferred to a microcentrifuge tube, and centrifuged at 17,000 x g for 5 minutes. A portion (20 µL) of the supernatant was then analyzed by HPLC. Sulfimide formation was quantified by comparison of integrated peak areas of internal standard (1,3,5-trimethoxy benzene, 1 mM or 1,3,5-trichlorobenzene, 1 mM) and sulfimide at 220 nm to a calibration curve made using synthetically produced sulfimide and internal standard.
Coefficients determined from standard curves were multiplied by a dilution factor in order to obtain sulfimide concentrations in the reaction mixture. Standard curves and response factors for products 8a-8d are presented in Figures S12-S15 below. For chiral HPLC, the quenched reaction mixture was extracted twice with ethyl acetate (2 x 350 µL), dried under a light argon stream and resuspended in acetonitrile (100 µL).
Controls to confirm the enzymatic sulfimidation activity of variant P411 BM3 CIS T438S.
Small-scale reactions (400 µL total volume) were set up and worked up as described above. For the reaction containing hemin as catalyst, 10 µL of a hemin solution (1 mM in 50% DMSO-H 2 O) was added to a final concentration of 25 µM. TTNs were determined as described above
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and are presented in Table S2 . CS denotes 'complete system' in which all components of the reactions as described above are present. Variations from the complete system are denoted with a "-X" where X is the component removed.
Synthesis of substrates and standards
All sulfides presented in Table 2 were obtained from commercial sources (Sigma Aldrich, Alfa Aesar). Sulfimide standards were synthesized as previously reported. Determination of initial rates. Four 2-ml vials were charged with a stir bar, 10x oxygen depletion system 3 (40 µL), and a solution of enzyme prior to crimp sealing with a silicon septum.
Once sealed, the headspace was flushed with argon for at least 10 minutes. Concurrently, a sealed 6-mL vial charged with glucose (250 mM, 400 µL), NADPH (20 mM, 400 µL), and KPi (pH = 8.0, 0.1 M, 2.6 mL) was sparged for 10 minutes with argon. After degassing was complete, 340 µL of the reaction solution was transferred to the 2-mL vial via syringe. Sulfide (100 mM, 10 µL) was added to all four 2-mL vials followed quickly (less than 20 seconds) by tosyl azide (100 mM, 10 µL). The reactions were quenched at 1-2 minute intervals over 5-10 minutes by decapping and adding acetonitrile (460 µL). After 5 minutes of stirring, the vials were charged with internal standard and the reaction mixtures were transferred to 1.8 mL tubes, which were vortexed and centrifuged (14,000 x g, 5 min). The supernatant was transferred to a vial for analysis by HPLC. Initial rates are plotted for individual enzymes referenced in the text in Figure S2 , and for various substituted aryl sulfides in Figure S7 .
Visible absorbance spectroscopy and observation of resting states. To a semi-micro anaerobic cuvette, 8 µL of P411 BM3 CIS I263A T438S (400 µM) was added. To obtain a spectrum of the ferric protein, 0.5 mL of degassed phosphate buffer was added to the cuvette and the visible spectrum was recorded from 650 to 400 nm. To obtain a spectrum of the ferrous protein, the cuvette was sealed with a cap equipped with rubber septa and the headspace of the The appearance of ferrous heme is observed over time. HPLC confirmed formation of both sulfimide and sulfonamide.
Excess sulfide and azide slow addition experiments.
To assess the impact of sulfide concentration on overall productivity of reaction, sulfide was added to reaction ranging from 0.5 eq to 4 eq relative to azide. 1 eq of azide denotes 1 mM in the small scale reactions described above. Results are plotted in Figure S10 below as a ratio of the TTN for sulfimide vs. TTN for sulfonamide. Slow addition was accomplished by adding 1 µL of a 100 mM (100 nmol) tosyl azide solution (DMSO) at 15 minute intervals to a reaction set up as described previously with 0.4% catalyst loading, containing 2.5 mM 7a. Azide was added over 150 minutes until equimolar final concentrations of sulfide and azide were achieved. Results of the slow addition are presented in Figure S11 . Figure S1 . Azides tested as nitrene sources for sulfimidation of thioanisole using the P411 BM3 -CIS T438S enzyme. TTN = total turnover number. 
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Figure S2. Data used to determine initial rates of the reaction depicted in scheme above using the enzymes listed in figure legend. Table S3 . Initial rates determined from data presented in Figure S2 and TTNs presented in Table  1 . Table S4 . Qualitative description of reaction productivity using para-methoxy aryl sulfide 7a and azides shown in Figure S1 . Figure S3 . A) SFC trace of synthetic standard of 8a using Chiralpak OD-H column with 25% isopropanol/75% supercritical CO 2 mobile phase. B) Trace of P411 BM3 -CIS T438S produced 8a under same conditions as synthetic standard. C) Trace of P411 BM3 -H2-5-F10 produced 8a. D) Trace of P411 BM3 -CIS I263A T438S produced 8a, using 20 % isopropanol/80% supercritical CO 2 mobile phase. . Data used to determine initial rates for reaction of substituted aryl sulfides with tosyl azide, using P411 BM3 -CIS T438S as catalyst. Sulfimide products measured are as listed in Table  2 of the text. Figure S9 . Monitoring the iron heme during the sulfimidation reaction with azide and sulfide. As shown in Figure S8 , the Soret peak for the Fe(III) state is obscured by NADPH. Therefore the Q-band region (enlarged box from 530-640 nm) was used to assess the transition from Fe(III) to Fe(II) as reaction proceeds as described in the supplemental text. Figure S10 . Ratio of sulfimide TTN to sulfonamide TTN as sulfide concentration is varied, using P411 BM3 -CIS T438S enzyme, as shown in scheme. Reactions were assembled as described above, with azide concentration held constant at 1 mM and sulfide concentration varied from 0.5 mM to 4 mM. Figure S11 . TTN values measured for slow addition vs. adding substrates simultaneously, using P411BM3-CIS T438S enzyme and the substrates shown in Figure S10 . Light gray bar shows TTN for sulfonamide, 9, dark gray shows TTN for the sulfimide, 8a.
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Figure S12: Standard curve for product 8a, showing response factor as ratio of product area to internal standard area as described above (y-axis) and concentration of product injected (x-axis).
Concentration injected (mM)
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Figure S13. Standard curve for product 8b. 
